Abiraterone Acetate Diastereomer
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Abiraterone Acetate Diastereomer

● Under Development

Catalogue No.:VL830014
CAS No.:N/A
Mol. Formula:C26H33NO2
Mol. Weight:391.56 g/mol

Additional information on Abiraterone Acetate Diastereomer

Parent drug

Abiraterone

IUPAC Name

(3S, 8R, 9S, 10R, 13S, 14S)-10, 13-dimethyl-17-(pyridin-3-yl)-2, 3, 4, 7, 8, 9, 10, 11, 12, 13, 14, 15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

Pharmacopoeial Synonyms

N/A

Other Synonyms

17-(Pyridin-3-yl)androsta-5,16-dien-3B-yl acetate

Smiles

CC(O[C@H]1CC[C@]2(C)[C@@]3([H])CC[C@]4(C)C(C5=CC=CN=C5)=CC[C@@]4([H])[C@]3([H])CC=C2C1)=O

InChI

InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1

Description

Abiraterone Acetate Diastereomer is an enantiomer of abiraterone acetate prescribed for patients with castration-resistant prostate cancer. Abiraterone -acetate is a prodrug that is converted in vivo to abiraterone having an androgen biosynthesis inhibitory property.

References

Mach, Samuel, et al. “Epoxidation Is the Preferred Pathway of First-Stage Metabolism of Abiraterone Acetate in Brown Bullhead (Ameiurus Nebulosus).” Environmental Science and Pollution Research, vol. 26, no. 34, Oct. 2019, pp. 34896–904, https://doi.org/10.1007/s11356-019-06568-y.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url